Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Béringue V[au]:

High-Pressure Response of Amyloid Folds. Torrent J et al. Viruses. (2019)

Prion Strains and Transmission Barrier Phenomena. Igel-Egalon A et al. Pathogens. (2018)

Causative Links between Protein Aggregation and Oxidative Stress: A Review. Lévy E et al. Int J Mol Sci. (2019)

Search results

Items: 1 to 50 of 93

1.

Early stage prion assembly involves two subpopulations with different quaternary structures and a secondary templating pathway.

Igel-Egalon A, Laferrière F, Moudjou M, Bohl J, Mezache M, Knäpple T, Herzog L, Reine F, Jas-Duval C, Doumic M, Rezaei H, Béringue V.

Commun Biol. 2019 Oct 4;2(1):363. doi: 10.1038/s42003-019-0608-y.

PMID:
31925195
2.

A farewell to outgoing Editor-in-Chief Michel Brémont.

Coulamy E, Béringue V.

Vet Res. 2019 Nov 11;50(1):93. doi: 10.1186/s13567-019-0711-6. No abstract available.

3.

Early stage prion assembly involves two subpopulations with different quaternary structures and a secondary templating pathway.

Igel-Egalon A, Laferrière F, Moudjou M, Bohl J, Mezache M, Knäpple T, Herzog L, Reine F, Jas-Duval C, Doumic M, Rezaei H, Béringue V.

Commun Biol. 2019 Oct 4;2:363. doi: 10.1038/s42003-019-0608-y. eCollection 2019.

4.

Prion strain-dependent tropism is maintained between spleen and granuloma and relies on lymphofollicular structures.

Al-Dybiat I, Moudjou M, Martin D, Reine F, Herzog L, Truchet S, Berthon P, Laude H, Rezaei H, Andréoletti O, Béringue V, Sibille P.

Sci Rep. 2019 Oct 10;9(1):14656. doi: 10.1038/s41598-019-51084-1.

5.

Causative Links between Protein Aggregation and Oxidative Stress: A Review.

Lévy E, El Banna N, Baïlle D, Heneman-Masurel A, Truchet S, Rezaei H, Huang ME, Béringue V, Martin D, Vernis L.

Int J Mol Sci. 2019 Aug 9;20(16). pii: E3896. doi: 10.3390/ijms20163896. Review.

6.

Thermostability as a highly dependent prion strain feature.

Marín-Moreno A, Aguilar-Calvo P, Moudjou M, Espinosa JC, Béringue V, Torres JM.

Sci Rep. 2019 Aug 6;9(1):11396. doi: 10.1038/s41598-019-47781-6.

7.

Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?

Igel-Egalon A, Bohl J, Moudjou M, Herzog L, Reine F, Rezaei H, Béringue V.

Viruses. 2019 May 10;11(5). pii: E429. doi: 10.3390/v11050429. Review.

8.

High-Pressure Response of Amyloid Folds.

Torrent J, Martin D, Igel-Egalon A, Béringue V, Rezaei H.

Viruses. 2019 Feb 28;11(3). pii: E202. doi: 10.3390/v11030202. Review.

9.

Pressure Reveals Unique Conformational Features in Prion Protein Fibril Diversity.

Torrent J, Martin D, Noinville S, Yin Y, Doumic M, Moudjou M, Béringue V, Rezaei H.

Sci Rep. 2019 Feb 26;9(1):2802. doi: 10.1038/s41598-019-39261-8.

10.

Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.

Hirsch TZ, Martin-Lannerée S, Reine F, Hernandez-Rapp J, Herzog L, Dron M, Privat N, Passet B, Halliez S, Villa-Diaz A, Lacroux C, Klein V, Haïk S, Andréoletti O, Torres JM, Vilotte JL, Béringue V, Mouillet-Richard S.

Mol Neurobiol. 2019 Mar;56(3):2159-2173. doi: 10.1007/s12035-018-1193-7. Epub 2018 Jul 11.

PMID:
29998397
11.

Prion Strains and Transmission Barrier Phenomena.

Igel-Egalon A, Béringue V, Rezaei H, Sibille P.

Pathogens. 2018 Jan 1;7(1). pii: E5. doi: 10.3390/pathogens7010005. Review.

12.

Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick.

Igel-Egalon A, Moudjou M, Martin D, Busley A, Knäpple T, Herzog L, Reine F, Lepejova N, Richard CA, Béringue V, Rezaei H.

PLoS Pathog. 2017 Sep 7;13(9):e1006557. doi: 10.1371/journal.ppat.1006557. eCollection 2017 Sep.

13.

Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.

Privat N, Levavasseur E, Yildirim S, Hannaoui S, Brandel JP, Laplanche JL, Béringue V, Seilhean D, Haïk S.

J Biol Chem. 2017 Oct 6;292(40):16688-16696. doi: 10.1074/jbc.M117.793646. Epub 2017 Aug 15.

14.

Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.

Douet JY, Lacroux C, Aron N, Head MW, Lugan S, Tillier C, Huor A, Cassard H, Arnold M, Beringue V, Ironside JW, Andréoletti O.

Emerg Infect Dis. 2017 Jun;23(6):946-956. doi: 10.3201/eid2306.161734.

15.

The double life of the ribosome: When its protein folding activity supports prion propagation.

Voisset C, Blondel M, Jones GW, Friocourt G, Stahl G, Chédin S, Béringue V, Gillet R.

Prion. 2017 Mar 4;11(2):89-97. doi: 10.1080/19336896.2017.1303587. Review.

16.

A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity.

Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Igel-Egalon A, Barbereau C, Chapuis J, Ciric D, Laude H, Béringue V, Rezaei H, Dron M.

Prion. 2017 Jan 2;11(1):25-30. doi: 10.1080/19336896.2016.1274851. Epub 2017 Feb 8.

17.

Cerebellar compartmentation of prion pathogenesis.

Ragagnin A, Ezpeleta J, Guillemain A, Boudet-Devaud F, Haeberlé AM, Demais V, Vidal C, Demuth S, Béringue V, Kellermann O, Schneider B, Grant NJ, Bailly Y.

Brain Pathol. 2018 Mar;28(2):240-263. doi: 10.1111/bpa.12503. Epub 2017 Apr 10.

PMID:
28268246
18.

Divergent prion strain evolution driven by PrPC expression level in transgenic mice.

Le Dur A, Laï TL, Stinnakre MG, Laisné A, Chenais N, Rakotobe S, Passet B, Reine F, Soulier S, Herzog L, Tilly G, Rézaei H, Béringue V, Vilotte JL, Laude H.

Nat Commun. 2017 Jan 23;8:14170. doi: 10.1038/ncomms14170.

19.

Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.

Bougard D, Brandel JP, Bélondrade M, Béringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Haïk S, Coste J.

Sci Transl Med. 2016 Dec 21;8(370):370ra182. doi: 10.1126/scitranslmed.aag1257.

PMID:
28003547
20.

Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice.

Jaumain E, Quadrio I, Herzog L, Reine F, Rezaei H, Andréoletti O, Laude H, Perret-Liaudet A, Haïk S, Béringue V.

J Virol. 2016 Nov 14;90(23):10867-10874. doi: 10.1128/JVI.01383-16. Print 2016 Dec 1.

21.

The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells.

Martin-Lannerée S, Halliez S, Hirsch TZ, Hernandez-Rapp J, Passet B, Tomkiewicz C, Villa-Diaz A, Torres JM, Launay JM, Béringue V, Vilotte JL, Mouillet-Richard S.

Stem Cells. 2017 Mar;35(3):754-765. doi: 10.1002/stem.2501. Epub 2016 Oct 3.

22.

Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.

Moudjou M, Chapuis J, Mekrouti M, Reine F, Herzog L, Sibille P, Laude H, Vilette D, Andréoletti O, Rezaei H, Dron M, Béringue V.

Sci Rep. 2016 Jul 7;6:29116. doi: 10.1038/srep29116.

23.

Generating Bona Fide Mammalian Prions with Internal Deletions.

Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Chapuis J, Ciric D, Igel-Egalon A, Laude H, Béringue V, Rezaei H, Dron M.

J Virol. 2016 Jul 11;90(15):6963-6975. doi: 10.1128/JVI.00555-16. Print 2016 Aug 1.

24.

Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.

Chapuis J, Moudjou M, Reine F, Herzog L, Jaumain E, Chapuis C, Quadrio I, Boulliat J, Perret-Liaudet A, Dron M, Laude H, Rezaei H, Béringue V.

Acta Neuropathol Commun. 2016 Feb 5;4:10. doi: 10.1186/s40478-016-0284-9.

25.

Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.

Belondrade M, Nicot S, Béringue V, Coste J, Lehmann S, Bougard D.

PLoS One. 2016 Jan 22;11(1):e0146833. doi: 10.1371/journal.pone.0146833. eCollection 2016.

26.

Prion protein localizes at the ciliary base during neural and cardiovascular development, and its depletion affects α-tubulin post-translational modifications.

Halliez S, Martin-Lannerée S, Passet B, Hernandez-Rapp J, Castille J, Urien C, Chat S, Laude H, Vilotte JL, Mouillet-Richard S, Béringue V.

Sci Rep. 2015 Dec 18;5:17146. doi: 10.1038/srep17146.

27.

Getting to the core of prion superstructural variability.

Torrent J, Lange R, Igel-Egalon A, Béringue V, Rezaei H.

Prion. 2016;10(1):1-8. doi: 10.1080/19336896.2015.1122161.

28.

Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.

Khalifé M, Reine F, Paquet-Fifield S, Castille J, Herzog L, Vilotte M, Moudjou M, Moazami-Goudarzi K, Makhzami S, Passet B, Andréoletti O, Vilette D, Laude H, Béringue V, Vilotte JL.

J Virol. 2015 Nov 25;90(3):1638-46. doi: 10.1128/JVI.02805-15. Print 2016 Feb 1.

29.

Transgenic Rabbits Expressing Ovine PrP Are Susceptible to Scrapie.

Sarradin P, Viglietta C, Limouzin C, Andréoletti O, Daniel-Carlier N, Barc C, Leroux-Coyau M, Berthon P, Chapuis J, Rossignol C, Gatti JL, Belghazi M, Labas V, Vilotte JL, Béringue V, Lantier F, Laude H, Houdebine LM.

PLoS Pathog. 2015 Aug 6;11(8):e1005077. doi: 10.1371/journal.ppat.1005077. eCollection 2015 Aug.

30.

Interaction between Shadoo and PrP Affects the PrP-Folding Pathway.

Ciric D, Richard CA, Moudjou M, Chapuis J, Sibille P, Daude N, Westaway D, Adrover M, Béringue V, Martin D, Rezaei H.

J Virol. 2015 Jun;89(12):6287-93. doi: 10.1128/JVI.03429-14. Epub 2015 Apr 8.

31.

Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases.

Torrent J, Vilchez-Acosta A, Muñoz-Torrero D, Trovaslet M, Nachon F, Chatonnet A, Grznarova K, Acquatella-Tran Van Ba I, Le Goffic R, Herzog L, Béringue V, Rezaei H.

Acta Neuropathol Commun. 2015 Apr 3;3:18. doi: 10.1186/s40478-015-0188-0.

32.

Evidence for zoonotic potential of ovine scrapie prions.

Cassard H, Torres JM, Lacroux C, Douet JY, Benestad SL, Lantier F, Lugan S, Lantier I, Costes P, Aron N, Reine F, Herzog L, Espinosa JC, Beringue V, Andréoletti O.

Nat Commun. 2014 Dec 16;5:5821. doi: 10.1038/ncomms6821.

PMID:
25510416
33.

To develop with or without the prion protein.

Halliez S, Passet B, Martin-Lannerée S, Hernandez-Rapp J, Laude H, Mouillet-Richard S, Vilotte JL, Béringue V.

Front Cell Dev Biol. 2014 Oct 13;2:58. doi: 10.3389/fcell.2014.00058. eCollection 2014. Review.

34.

The prion protein family: a view from the placenta.

Makzhami S, Passet B, Halliez S, Castille J, Moazami-Goudarzi K, Duchesne A, Vilotte M, Laude H, Mouillet-Richard S, Béringue V, Vaiman D, Vilotte JL.

Front Cell Dev Biol. 2014 Aug 8;2:35. doi: 10.3389/fcell.2014.00035. eCollection 2014. Review.

35.

Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity.

Nguyen PH, Hammoud H, Halliez S, Pang Y, Evrard J, Schmitt M, Oumata N, Bourguignon JJ, Sanyal S, Beringue V, Blondel M, Bihel F, Voisset C.

ACS Chem Neurosci. 2014 Oct 15;5(10):1075-82. doi: 10.1021/cn5001588. Epub 2014 Sep 22.

PMID:
25244284
36.

White blood cell-based detection of asymptomatic scrapie infection by ex vivo assays.

Halliez S, Jaumain E, Huor A, Douet JY, Lugan S, Cassard H, Lacroux C, Béringue V, Andréoletti O, Vilette D.

PLoS One. 2014 Aug 14;9(8):e104287. doi: 10.1371/journal.pone.0104287. eCollection 2014.

37.

Preclinical detection of variant CJD and BSE prions in blood.

Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O.

PLoS Pathog. 2014 Jun 12;10(6):e1004202. doi: 10.1371/journal.ppat.1004202. eCollection 2014 Jun.

38.

Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Halliez S, Reine F, Herzog L, Jaumain E, Haïk S, Rezaei H, Vilotte JL, Laude H, Béringue V.

J Virol. 2014 Aug;88(15):8678-86. doi: 10.1128/JVI.01118-14. Epub 2014 May 21.

39.

Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification.

Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferrière F, Richard CA, Laude H, Andréoletti O, Rezaei H, Béringue V.

mBio. 2013 Dec 31;5(1):e00829-13. doi: 10.1128/mBio.00829-13.

40.

Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.

Laferrière F, Tixador P, Moudjou M, Chapuis J, Sibille P, Herzog L, Reine F, Jaumain E, Laude H, Rezaei H, Béringue V.

PLoS Pathog. 2013;9(10):e1003702. doi: 10.1371/journal.ppat.1003702. Epub 2013 Oct 10.

41.

The toll-like receptor agonist imiquimod is active against prions.

Oumata N, Nguyen PH, Beringue V, Soubigou F, Pang Y, Desban N, Massacrier C, Morel Y, Paturel C, Contesse MA, Bouaziz S, Sanyal S, Galons H, Blondel M, Voisset C.

PLoS One. 2013 Aug 16;8(8):e72112. doi: 10.1371/journal.pone.0072112. eCollection 2013.

42.

Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection.

Segarra C, Bougard D, Moudjou M, Laude H, Béringue V, Coste J.

PLoS One. 2013 Jul 24;8(7):e69632. doi: 10.1371/journal.pone.0069632. Print 2013.

43.

Targeted knock-down of cellular prion protein expression in myelinating Schwann cells does not alter mouse prion pathogenesis.

Halliez S, Chesnais N, Mallucci G, Vilotte M, Langevin C, Jaumain E, Laude H, Vilotte JL, Béringue V.

J Gen Virol. 2013 Jun;94(Pt 6):1435-40. doi: 10.1099/vir.0.049619-0. Epub 2013 Feb 6.

PMID:
23388201
44.

Mammalian prions: tolerance to sequence changes-how far?

Salamat MK, Munoz-Montesino C, Moudjou M, Rezaei H, Laude H, Béringue V, Dron M.

Prion. 2013 Mar-Apr;7(2):131-5. doi: 10.4161/pri.23110. Epub 2012 Dec 11. Review.

45.

The prion protein family: looking outside the central nervous system.

Passet B, Halliez S, Béringue V, Laude H, Vilotte JL.

Prion. 2013 Mar-Apr;7(2):127-30. doi: 10.4161/pri.22851. Epub 2012 Nov 15. Review.

46.

Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development.

Passet B, Young R, Makhzami S, Vilotte M, Jaffrezic F, Halliez S, Bouet S, Marthey S, Khalifé M, Kanellopoulos-Langevin C, Béringue V, Le Provost F, Laude H, Vilotte JL.

PLoS One. 2012;7(7):e41959. doi: 10.1371/journal.pone.0041959. Epub 2012 Jul 30.

47.

[Tissue-specific cross-species transmission of prions].

Béringue V, Vilotte JL, Laude H.

Med Sci (Paris). 2012 Jun-Jul;28(6-7):565-8. doi: 10.1051/medsci/2012286002. Epub 2012 Jul 16. French. No abstract available.

48.

Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.

Cronier S, Carimalo J, Schaeffer B, Jaumain E, Béringue V, Miquel MC, Laude H, Peyrin JM.

FASEB J. 2012 Sep;26(9):3854-61. doi: 10.1096/fj.11-201772. Epub 2012 Jun 1.

PMID:
22661006
49.

Prion protein is a key determinant of alcohol sensitivity through the modulation of N-methyl-D-aspartate receptor (NMDAR) activity.

Petit-Paitel A, Ménard B, Guyon A, Béringue V, Nahon JL, Zsürger N, Chabry J.

PLoS One. 2012;7(4):e34691. doi: 10.1371/journal.pone.0034691. Epub 2012 Apr 20.

50.

Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication.

Salamat K, Moudjou M, Chapuis J, Herzog L, Jaumain E, Béringue V, Rezaei H, Pastore A, Laude H, Dron M.

J Biol Chem. 2012 Jun 1;287(23):18953-64. doi: 10.1074/jbc.M112.341677. Epub 2012 Apr 16.

Supplemental Content

Loading ...
Support Center